Atrium Innovations Buys Dietary Supplement Maker Seroyal International

Canadian nutrition supplement maker Atrium Innovations Inc. has acquired Ontario-based Seroyal International, a provider of premium dietary supplement brands targeting healthcare practitioners channels in Canada and in the U.S. Seroyal’s annual revenues are about US$40 million. Ninety percent of Seroyal’s sales come from three main products: Genestra, Unda and Pharmax. Another brand, the joint venture-owned CoreLab, is a health food store brand sold in the U.S. Atrium acquired Seroyal for a total cash consideration of US$110 million plus future earn-out payments. Atrium markets a portfolio of dietary supplements for the health and nutrition industry in more than 35 countries, primarily in North America and Europe. According to Atrium CEO, the acquisition ”adds premium, high margin and complementary brands” to Atrium’s product line.